The prostate stem cell antigen represents a novel glioma-associated antigen

Oncology Reports

Volumn 26, Issue 1, 2011, Pages 13-21

  Geiger, K D ^a   Hendruschk, S ^b   Rieber, E P ^a   Morgenroth, A ^a   Weigle, B ^a   Juratli, T ^b   Senner, V ^c   Schackert, G ^b   Temme, A ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Gliomas; Prostate stem cell antigen; RT PCR; Tumor associated antigen

Indexed keywords

GLIOMA ASSOCIATED ANTIGEN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; PROSTATE STEM CELL ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; ASTROCYTOMA; BRAIN TISSUE; CANCER GRADING; CONTROLLED STUDY; EPENDYMOMA; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN TARGETING; TUMOR DIAGNOSIS;

ANTIGENS; ANTIGENS, NEOPLASM; BRAIN NEOPLASMS; CELL SEPARATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; GLYCOSYLATION; GPI-LINKED PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79955877559     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1265     Document Type: Article

References (38)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109, 2007.
2. Kocher M, Frommolt P, Borberg SK, Ruhl U, Steingraber M, Niewald M, Staar S, Stuschke M, Becker G, Fischedick AR, Herfarth K, Grauthoff H and Muller RP: Randomized study of postoperative radiotherapy and simultaneous temozolomide without adjuvant chemotherapy for glioblastoma. Strahlenther Onkol 184: 572-579, 2008.
3. + cell-mediated immunity against tumors located in the 'immunologically privileged' central nervous system. Proc Natl Acad Sci USA 93: 10399-10404, 1996.
4. Okada H, Kohanbash G, Zhu X, Kastenhuber ER, Hoji A, Ueda R and Fujita M: Immunotherapeutic approaches for glioma. Crit Rev Immunol 29: 1-42, 2009.
5. Yu JS, Wheeler CJ, Zeltzer PM, Ying H, Finger DN, Lee PK, Yong WH, Incardona F, Thompson RC, Riedinger MS, Zhang W, Prins RM and Black KL: Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Res 61: 842-847, 2001. (Pubitemid 32175145)
6. Ueda R, Kinoshita E, Ito R, Kawase T, Kawakami Y and Toda M: Induction of protective and therapeutic antitumor immunity by a DNA vaccine with a glioma antigen, SOX6. Int J Cancer 122: 2274-2279, 2008. (Pubitemid 351542331)
7. Kuan CT, Wikstrand CJ and Bigner DD: EGFRvIII as a promising target for antibody-based brain tumor therapy. Brain Tumor Pathol 17: 71-78, 2000.
8. Ahmed N, Ratnayake M, Savoldo B, Perlaky L, Dotti G, Wels WS, Bhattacharjee MB, Gilbertson RJ, Shine HD, Weiss HL, Rooney CM, Heslop HE and Gottschalk S: Regression of experimental medulloblastoma following transfer of HER2-specific T cells. Cancer Res 67: 5957-5964, 2007. (Pubitemid 46985032)
9. Liu G, Ying H, Zeng G, Wheeler CJ, Hack KL and Yu JS: HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells. Cancer Res 64: 4980-4986, 2004. (Pubitemid 38924546)
10. Zhang JG, Eguchi J, Kruse CA, Gomez GG, Fakhrai H, Schroter S, Ma W, Hoa N, Minev B, Delgado C, Wepsic HT, Okada H and Jadus MR: Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics. Clin Cancer Res 13: 566-575, 2007. (Pubitemid 46225363)
11. Komata T, Kanzawa T, Kondo Y and Kondo S: Telomerase as a therapeutic target for malignant gliomas. Oncogene 21: 656-663, 2002. (Pubitemid 34146268)
12. Katoh M, Wilmotte R, Belkouch MC, De Tribolet N, Pizzolato G and Dietrich PY: Survivin in brain tumors: an attractive target for immunotherapy. J Neurooncol 64: 71-76, 2003. (Pubitemid 36992462)
13. Schmitz M, Temme A, Senner V, Ebner R, Schwind S, Stevanovic S, Wehner R, Schackert G, Schackert HK, Fussel M, Bachmann M, Rieber EP and Weigle B: Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy. Br J Cancer 96: 1293-1301, 2007. (Pubitemid 46625072)
14. Schmitz M, Wehner R, Stevanovic S, Kiessling A, Rieger MA, Temme A, Bachmann M, Rieber EP and Weigle B: Identification of a naturally processed T cell epitope derived from the glioma-associated protein SOX11. Cancer Lett 245: 331-336, 2007. (Pubitemid 44959365)
15. Weigle B, Ebner R, Temme A, Schwind S, Schmitz M, Kiessling A, Rieger MA, Schackert G, Schackert HK and Rieber EP: Highly specific overexpression of the transcription factor SOX11 in human malignant gliomas. Oncol Rep 13: 139-144, 2005.
16. Ehtesham M, Black KL and Yu JS: Recent progress in immunotherapy for malignant glioma: treatment strategies and results from clinical trials. Cancer Control 11: 192-207, 2004. (Pubitemid 38758224)
17. Antica M, Wu L and Scollay R: Stem cell antigen 2 expression in adult and developing mice. Immunol Lett 55: 47-51, 1997. (Pubitemid 27117494)
18. Classon BJ and Coverdale L: Mouse stem cell antigen Sca-2 is a member of the Ly-6 family of cell surface proteins. Proc Natl Acad Sci USA 91: 5296-5300, 1994. (Pubitemid 24174313)
19. Reiter RE, Gu Z, Watabe T, Thomas G, Szigeti K, Davis E, Wahl M, Nisitani S, Yamashiro J, Le Beau MM, Loda M and Witte ON: Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci USA 95: 1735-1740, 1998. (Pubitemid 28103463)
20. Lam JS, Yamashiro J, Shintaku IP, Vessella RL, Jenkins RB, Horvath S, Said JW and Reiter RE: Prostate stem cell antigen is overexpressed in prostate cancer metastases. Clin Cancer Res 11: 2591-2596, 2005. (Pubitemid 40569458)
21. Amara N, Palapattu GS, Schrage M, Gu Z, Thomas GV, Dorey F, Said J and Reiter RE: Prostate stem cell antigen is overexpressed in human transitional cell carcinoma. Cancer Res 61: 4660-4665, 2001. (Pubitemid 32691871)
22. Argani P, Rosty C, Reiter RE, Wilentz RE, Murugesan SR, Leach SD, Ryu B, Skinner HG, Goggins M, Jaffee EM, Yeo CJ, Cameron JL, Kern SE and Hruban RH: Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res 61: 4320-4324, 2001. (Pubitemid 32685751)
23. Elsamman EM, Fukumori T, Tanimoto S, Nakanishi R, Takahashi M, Toida K and Kanayama HO: The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis. BJU Int 98: 668-673, 2006. (Pubitemid 44185896)
24. Tanaka M, Komatsu N, Terakawa N, Yanagimoto Y, Oka M, Sasada T, Mine T, Gouhara S, Shichijo S, Okuda S and Itoh K: Increased levels of IgG antibodies against peptides of the prostate stem cell antigen in the plasma of pancreatic cancer patients. Oncol Rep 18: 161-166, 2007.
25. + T cells in prostate cancer patients. Int J Cancer 102: 390-397, 2002. (Pubitemid 35276525)
26. Garcia-Hernandez ML, Gray A, Hubby B, Klinger OJ and Kast M: Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity. Cancer Res 68: 861-869, 2008. (Pubitemid 351206764)
27. Saffran DC, Raitano AB, Hubert RS, Witte ON, Reiter RE and Jakobovits A: Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts. Proc Natl Acad Sci USA 98: 2658-2663, 2001. (Pubitemid 32209538)
28. Ross S, Spencer SD, Holcomb I, Tan C, Hongo J, Devaux B, Rangell L, Keller GA, Schow P, Steeves RM, Lutz RJ, Frantz G, Hillan K, Peale F, Tobin P, Eberhard D, Rubin MA, Lasky LA and Koeppen H: Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate. Cancer Res 62: 2546-2553, 2002. (Pubitemid 34462733)
29. Cunha AC, Weigle B, Kiessling A, Bachmann M and Rieber EP: Tissue-specificity of prostate specific antigens: comparative analysis of transcript levels in prostate and non-prostatic tissues. Cancer Lett 236: 229-238, 2006.
30. Morgenroth A, Cartellieri M, Schmitz M, Gunes S, Weigle B, Bachmann M, Abken H, Rieber EP and Temme A: Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells. Prostate 67: 1121-1131, 2007. (Pubitemid 46983341)
31. Strommer K, Hamou MF, Diggelmann H and de TN: Cellular and tumoural heterogeneity of EGFR gene amplification in human malignant gliomas. Acta Neurochir (Wien) 107: 82-87, 1990.
32. Lu Y, Chen J, Ding Y, Jin G, Wu J, Huang H, Deng B, Hua Z, Zhou Y, Shu Y, Liu P, Hu Z, Shen J, Xu Y and Shen H: Genetic variation of PSCA gene is associated with the risk of both diffuse-and intestinal-type gastric cancer in a Chinese population. Int J Cancer 127: 2183-2189, 2010.
33. Liu WK, Jiang XY and Zhang ZX: Expression of PSCA, PIWIL1 and TBX2 and its correlation with HPV16 infection in formalin-fixed, paraffin-embedded cervical squamous cell carcinoma specimens. Arch Virol 155: 657-663, 2010.
34. Liu WK, Jiang XY and Zhang ZX: Expression of PSCA, PIWIL1, and TBX2 in endometrial adenocarcinoma. Onkologie 33: 241-245, 2010.
35. Witz IP: Differential expression of genes by tumor cells of a low or a high malignancy phenotype: the case of murine and human Ly-6 proteins. J Cell Biochem (Suppl) 34: 61-66, 2000.
36. Marra E, Uva P, Viti V, Simonelli V, Dogliotti E, De RE, Lahm A, La MN, Nicosia A, Giliberto G and Palombo F: Growth delay of human bladder cancer cells by prostate stem cell antigen downregulation is associated with activation of immune signaling pathways. BMC Cancer 10: 129, 2010.
37. Hruska M, Keefe J, Wert D, Tekinay AB, Hulce JJ, Ibanez-Tallon I and Nishi R: Prostate stem cell antigen is an endogenous lynx1-like prototoxin that antagonizes alpha7-containing nicotinic receptors and prevents programmed cell death of parasympathetic neurons. J Neurosci 29: 14847-14854, 2009.
38. Sharma G and Vijayaraghavan S: Nicotinic receptor signaling in nonexcitable cells. J Neurobiol 53: 524-534, 2002. (Pubitemid 35375583)